Free briefings

Updated daily.

Start with the free brief, then choose your edition

Pick the edition you care about and start with the free daily + weekly brief. Scan what changed in minutes, then open the original sources when you need more.

Choose what to receive:

Active edition: AI

Daily briefings on AI labs, policy, tooling, and community shifts.

Today's Brief
AI
EUR 19/mo

Daily briefings on AI labs, policy, tooling, and community shifts.

Updated daily.

Best for
  • Model releases + evals
  • Policy and safety narratives
  • Tooling and platform shifts
Flagship sampleUnlocked today
Coverage centers on: Military AI Policy Needs Democratic Oversight.
Today's Brief
Crypto
EUR 29/mo

Daily briefings on markets, protocols, narratives, and risk events.

Updated daily.

Best for
  • Market structure + regulation
  • Security and exploit narratives
  • Protocol + dev ecosystem
Flagship sampleUnlocked today
Coverage centers on: Bitcoin Braces for $60,000 Retest: What Technical Indicators Say About March Outlook.
Today's Brief
CYBERSECURITY
EUR 29/mo

Daily briefings on vulnerabilities, incidents, and threat intel.

Updated daily.

Best for
  • Vulns and advisories
  • Incidents + exploit narratives
  • Vendor and community disclosures
Flagship sampleUnlocked today
A global operation led by Europol and Microsoft has successfully dismantled the Tycoon 2FA phishing-as-a-service platform, which was responsible for a signif...
Today's Brief
ENERGY
EUR 19/mo

Daily briefings on the energy transition: policy, grid, storage, and markets.

Updated daily.

Best for
  • Grid + reliability narratives
  • Policy + first-party data
  • Storage + transition supply chain
Flagship sampleUnlocked today
Coverage discusses speculative scenarios around ~$20K; treat as market chatter and see linked sources.
Today's Brief
BIOTECH
EUR 29/mo

Daily briefings on clinical, regulatory, and R&D updates from public sources.

Updated daily.

Best for
  • Clinical + regulatory narratives
  • Research + preprints
  • Funding + market updates
Flagship sampleUnlocked today
J&J's Tecvayli claims third national priority FDA approval Phil.Taylor Fri, 06/03/2026 - 10:59.

How to choose

Pick the edition that matches the questions you want answered before the workday starts.

AI

Frontier labs, Policy, Tooling

Crypto

Market narratives, Social momentum, Risk watch

CYBERSECURITY

Vulns, Incidents, Threat intel

ENERGY

Grid, Policy, Transition

BIOTECH

Clinical, Regulation, R&D

How it works

Built to reduce duplication and hype - with source links you can verify.

Read widely

News, social, dev channels, and primary sources.

Remove duplicates

Filter rewrites, SEO clones, and repeated takes.

Group what belongs together

So you see one story, not 20 scattered posts.

Deliver the briefing

A daily scan + drill-down with source links.

Already have access?

New users should start with the free brief above. If you already have access, jump straight to your edition or compare Pro pricing.

Direct links (skip the hub picker):